
Harjinder Singh
DirectorMassey Institute of Food Science and Technology, NEW ZEALAND

Submitted
2025/03/21First Online
2025/06/12doi
10.18805/ajdfr.DRF-527Cite article - Othman Faisal Abdullah, Dhyiaa A. Jasim, Qusay S. Atwan, Ahmed Flayyih Hasan, Hany M. El-Wahsh. (2025). Biochemical and Total Antioxidant Effects of Iron Oxide Nanoparticles on Liver Mice. Asian Journal of Dairy and Food Research. 44: 218–223. doi: 10.18805/ajdfr.DRF-527
Background: This study focused on Iron oxide nanoparticles (Fe 2 O 3 -NPs) from multiple concentrations of Iron oxide nanoparticles (Fe 2 O 3 -NPs) on oxidation of lipids, the defence system of antioxidants and biochemical measurements in the liver of male mice.
Methods: Twenty male Albino Mice weighing 25-30 g were used in the study. Animals were categorised into four groups, each comprising 10 mice. The initial group served as the control. Groups II, III and IV received oral administration of Tin oxide nanoparticles at 50, 25 and 10 mg/kg weight body per day for four weeks. Blood and liver samples were collected after the experimental period to investigate various parameters.
Result: Treatment with Iron oxide nanoparticles (Fe 2 O 3 -NPsin) varying concentrations elevated levels of in comparison to the control group, the liver and kidneys exhibited reduced glutathione (GSH) content, glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase (GST) activities, as well as hydrogen peroxide (H 2 O 2 ) and thiobarbituric acid reactive substances (TBARS). The protein contents of rats were significantly reduced when they were administered iron oxide nanoparticles (Fe 2 O 3 -NPs) at concentrations that differed from those of the control group. Treatment with iron oxide nanoparticles (Fe 2 O 3 -NPs) at varying concentrations substantially increased urea and creatinine. In mice, an increase in urea and creatinine concentration is a substantial indicator of liver dysfunction. In mouse liver homogenates, the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were significantly reduced when treated with iron oxide nanoparticles (Fe 2 O 3 -NPs) at varying concentrations. Conversely, lactate dehydrogenase (LDH) was significantly increased. It is clear that iron oxide nanoparticles (Fe 2 O 3 -NPs) induce pronounced hazardous effects in the liver of mice in a dose-dependent manner, Biomarkers for the detrimental effects of iron oxide nanoparticles (Fe 2 O 3 -NPs) may include estimating lipid peroxidation, enzymatic and non-enzymatic antioxidants and biochemical parameters.
Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.
View Full Board